DrugDashboards

Pasatru

garetosmab-grts · GARETOSMAB 300 mg/5mL · Injection, Solution, Concentrate · Intravenous · Regeneron Pharmaceuticals, Inc.

NDC 61755-0012-01 · 1 VIAL, SINGLE-DOSE in 1 CARTON / 5 mL in 1 VIAL, SINGLE-DOSE · BLA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$53,307.00
Reported to Texas DSHS · 2026 annual filing · Regeneron Pharmaceuticals, Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 2 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
BLA761508
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of garetosmab-grts (Injection, Solution, Concentrate)

LabelerStrengthFirst seenLast seen
Regeneron Pharmaceuticals, Inc.GARETOSMAB 300 mg/5mLAug 26, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Pasatru — NDC 61755-0012-01," retrieved September 3, 2026, https://drugdashboards.com/drug/61755001201.

Free to cite with attribution — see how the data is put together.